RenBio is a biotechnology company based in the heart of New York City, founded by the desire to revolutionize antibody-based prevention and treatment of diseases. 

Changing the Treatment Landscape

RenBio’s antibody delivery system is compatible with any antibody and serves as a true platform technology with the potential to fundamentally change the antibody treatment landscape.